Skip to content
healthcare.dev

Cytarabine

NDC 68083-343, Cytarabine, injection, solution, from Gland Pharma Limited.

Product NDC
68083-343
Status
Listed
Labeler
Gland Pharma Limited
Dosage form
INJECTION, SOLUTION
Route
INTRATHECAL, INTRAVENOUS, SUBCUTANEOUS
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA211937
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/68083-343 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • CYTARABINE20 mg/mL

Pharmacologic classes

Nucleic Acid Synthesis Inhibitors [MoA]; Nucleoside Metabolic Inhibitor [EPC]

Package NDCNDC-11Package
68083-343-05680830343055 VIAL, SINGLE-DOSE in 1 CARTON (68083-343-05) / 5 mL in 1 VIAL, SINGLE-DOSE (68083-343-01)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/7ab50348-ca78-46a5-aba6-c35b6b21fbfe

Use it

Look up 68083-343 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/68083-343 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 68083-343. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.